Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board”

Becton, Dickinson and Company (NYSE:BDX) was one of the stocks featured in Jim Cramer’s Mad Money recap, as he discussed how the AI build-out could power the economy. Cramer highlighted the company’s latest quarterly earnings result, as he said:

This morning, we got a strong quarter from Becton, Dickinson and Company, which is one of the major medical supply and medical technology companies. After spending the last five years with some fine growth, Becton, Dickinson really shot the lights out with this one. Huge top and bottom line beat, management raising the full year earnings forecast, and that sent the stock up nearly 6% today on a not-so-great day for the market. The company showed excellent execution across the board. They’re getting a real boost from all sorts of technology that helps hospitals do more with fewer people.

Becton, Dickinson and Company (NYSE:BDX) sells a significant variety of medical supplies, diagnostic tools, and lab equipment used by healthcare professionals and researchers.

While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years

Disclosure: None. Follow Insider Monkey on Google News.